Year: 2015
Type: preprint
Abstract: Humans age at different rates and families with exceptional survival provide the opportunity to understand why some people age slower than others. Unique features exhibited by centenarians include a family history of longevity, compression of morbidity with resultant extension of health span, and biomarkers such as low-circulating insulin-like growth factor 1 (IGF-1) and elevated high-density lipoprotein (HDL) cholesterol levels. Given the rarity of the centenarian phenotype, it has not been surprising that the use of discovery methods that relied on common population single nucleotide polymorphisms (SNPs) to unlock the genetic determinants of exceptional longevity have not yielded significant results. Conversely, gene sequencing has resulted in discoveries of functional gene variants that support several of the centenarian phenotypes. These discoveries have led to the strategic developments of drugs that may delay aging and prolong health span.
Authors: Sofiya Milman, Nir Barzilai
Institution: Albert Einstein College of Medicine
Language: English
Subfield: Aging
Domain: Life Sciences
Open Access status: bronze
Awards: Excess nutrients and the metabolic syndrome of aging, Clinical and Translational Science Award, G4285553338, Clinical and Translational Science Award, Einstein's Nathan Shock Center of Excellence in Basic Biology of Aging, Dysregulation of Glucose Homeostasis in Aging, Effect of longevity genomes on the GH/IGF-1 phenotype and disease-free survival, LGP/Longenity, Multi-omics approach to frailty resilience
OpenAlex ID: W2193465455
